PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | |diabetes |
| Sentences | 200 |
| PubMedID- 23442745 | Background: the aim of this study was to evaluate the relationship between postprandial glucose level and atherosclerosis in patients without diabetes and cardiovascular disease by determining carotid ultrasonographic variables and serum levels of 1,5-anhydroglucitol (1,5-ag). |
| PubMedID- 24339286 | Won, et al.18 recently reported that ms and its individual components had a significant impact on subclinical atherosclerosis in conditions without diabetes, and a concurrent diagnosis of ms in subjects with established diabetes might be of little value for the risk stratification of cvd. |
| PubMedID- 21816064 | Among them, high glucose-induced endothelial cell apoptosis has been noted in the pathogenesis of the acceleration of atherosclerosis associated with diabetes [6,9]. |
| PubMedID- 25405332 | Furthermore, in people with type 2 diabetes, the roles of uric acid in atherosclerosis and cvd might be affected by other interactive risk factors that are related to atherosclerosis and cvd. |
| PubMedID- 22440543 | Periodontitis and diabetes associations with measures of atherosclerosis and chd. |
| PubMedID- 23936869 | Other signs include type 2 diabetes mellitus, osteoporosis, evidence of premature atherosclerosis, malignances, voice changes, and flat feet. |
| PubMedID- 21761004 | The japanese primary prevention of atherosclerosis with aspirin for diabetes (jpad) trial was the first prospective trial to evaluate the use of aspirin (81 or 100 mg) in the primary prevention of ischemic events in diabetic type 2 patients (n = 2,539), aged 30–85 years, in japan [15]. |
| PubMedID- 24741463 | Response: association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes (endocrinol metab 2013;28:309-19, chan-hee jung et al.) |
| PubMedID- PMC4595464 | Dogs and cats seem less prone to developing atherosclerosis compared with humans, while diabetes is a relatively common endocrine disease in both species. |
| PubMedID- 25253014 | [evaluation of left ventricular myocardial function in coronary atherosclerosis patients with type 2 diabetes mellitus by speckle tracking echocardiography]. |
| PubMedID- 26026780 | The aim of our study was to evaluate the relationship between thioredoxin-interacting protein (txnip) as an oxidative stress parameter and carotid artery intima-media thickness (cimt) as an indicator of atherosclerosis in patients with early-state diabetes and impaired glucose tolerance. |
| PubMedID- 23248194 | diabetes and risk of fracture-related hospitalization: the atherosclerosis risk in communities study. |
| PubMedID- 22447019 | To clarify the effect of the primary prevention of aspirin therapy in diabetic patients, the relationship between blood pressure (bp) and the incidence of atherosclerotic events was investigated in participants in the japanese primary prevention of atherosclerosis with aspirin for diabetes (jpad) trial. |
| PubMedID- 25875738 | However, little is known about the association between glycemic control and objective sleep architecture and its influence on arteriosclerosis in patients with type-2 diabetes mellitus (dm). |
| PubMedID- 24768387 | Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: prologue study. |
| PubMedID- 23761984 | The cross-linking activity is aimed at stabilizing the interaction of microtubules with the plasma membrane, demonstrating that transglutaminase activity can affect protein secretion and matrix deposition in osteoblasts.54,55 fxiii has been shown to have a direct role on vascular endothelial cells in promoting angiogenesis in vitro and in vivo on animal models.56 insulin resistance and diabetes mellitus is associated with prothrombotic states, atherosclerosis, dyslipidemia, and obesity. |
| PubMedID- 24194733 | atherosclerosis in diabetes, though accelerated, does not seem to be very different from atherosclerosis in individuals without diabetes type 2, although certain diabetes-specific factors could contribute to pro-atherogenic immune activation and thus aggravate atherosclerosis and risk of cvd. |
| PubMedID- 21615922 | In addition to the well-known diabetes-associated risk of coronary atherosclerosis, also metabolic changes and increased triglyceride deposition in the diabetic myocardium are likely to contribute to the development of compromised cardiac function in patients with type 2 diabetes. |
| PubMedID- 21264118 | Because concomitant administration of gliclazide with provastatin and gemfibrozil in diabetes is associated with atherosclerosis, it should be contraindicated or used with caution. |
| PubMedID- 20804545 | In this study we used whole body-mr-angiography (wb-mra) to assess the degree of atherosclerosis in patients with long-standing diabetes and to determine the association between metabolic syndrome (mets) and atherosclerotic burden. |
| PubMedID- 24089535 | The more advanced atherosclerosis of women with diabetes was another significant factor predicting a worse prognosis, in accordance with the results of the multivariate analysis. |
| PubMedID- 24843385 | Reported that parameters of glycemic variability calculated from cgm data, such as sd and mage, were increased as atherosclerosis progressed in patients with type 2 diabetes, and that increases in carotid intima-media thickness correlated significantly with mage [18]. |
| PubMedID- 20580029 | Faster progression of coronary atherosclerosis in women with diabetes could be mediated in part by a worse lipoprotein profile in these women than in women without diabetes, both before and during hrt. |
| PubMedID- 22267416 | Intima-media thickness and other markers of atherosclerosis in patients with type 2 diabetes and periodontal disease. |
| PubMedID- 20672024 | The comparison of pioglitazone versus glimepiride on progression of coronary atherosclerosis in patients with type-2 diabetes; the periscope trial [68], randomized 543 patients with cad and type-2 diabetes to receive one of the two commonly prescribed oral hypoglycemic agents, pioglitazone or glimipride. |
| PubMedID- 22389816 | It is also a risk factor for hypercholesterolaemia, per se [251], and for carotid artery atherosclerosis in men with diabetes [252]. |
| PubMedID- 25975128 | [a relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 26198368 | Accelerated atherosclerosis in patients with diabetes mellitus contributes an increased risk of developing cardiovascular diseases including peripheral vascular disease (pvd). |
| PubMedID- 22421230 | Objectives: the goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (met syn) presenting with acute coronary syndromes (acs). |
| PubMedID- 24476202 | Early recognition of asymptomatic atherosclerosis in diabetes would be certainly important in reducing the risk of diabetic macrovascular complication and improvement of the prognosis. |
| PubMedID- 25619262 | [30] explored aspects of nadph oxidase c242t polymorphism in pathogenesis of carotid atherosclerosis in patients with type 2 diabetes, and found no significant association of c242t polymorphism in the nadph gene with clinical parameters, including plaque score and intima-media thickness of the carotid artery, using the 75th percentile of intima-media thickness as a cut-off value. |
| PubMedID- 25385870 | It is well known that hyperglycemia is a trigger of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 21227528 | Association of serum trail levels with atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 26578953 | The frequency of cardiac events is higher and the progression of atherosclerosis is bigger in patients with diabetes compared to age-matched healthy controls. |
| PubMedID- 26345606 | Therefore, serms may also be effective in reducing the progression of arteriosclerosis in patients with diabetes mellitus. |
| PubMedID- 24593955 | Altered lipids and lipoprotein metabolism in chronic diabetes mellitus is associated with pathogenesis of atherosclerosis and other cardiovascular diseases [5]. |
| PubMedID- 24988089 | This might be one of the causal pathogenic factors initiating accelerated atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22738646 | Several adipokines have been reported to promote arterial stiffness, inflammation and atherosclerosis in subjects with diabetes and coronary heart disease[25-27]. |
| PubMedID- 21150011 | Progression of carotid atherosclerosis in diabetes patients showed analogous attenuation upon controlling for other cvd risks122. |
| PubMedID- 26161507 | Chronic kidney disease (ckd) is associated with atherosclerosis in patients with diabetes mellitus (dm) and in nondiabetic individuals [1]. |
| PubMedID- 21957962 | Then, the accumulation of 7-ketocholesterol together with total sterols may aggravate the development of atherosclerosis in diabetes mellitus. |
| PubMedID- 24152423 | It has been also described that preclinical atherosclerosis is associated with type 1 diabetes in young adults [32] and with gestational diabetes [33,34], showing an increased c-imt in these patients comparing it to controls. |
| PubMedID- 25889178 | In selected populations, such as patients with type 2 diabetes, the role of uric acid in atherosclerosis might result from other concomitant atherosclerotic risk factors, such as ckd. |
| PubMedID- 23918294 | Excessive weight has numerous negative health implications (arterial hypertension, type ii diabetes, diseases of the musculoskeletal system, atherosclerosis and heart disease, psychological problems) [1, 7]. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) [22], in subjects with early asymptomatic carotid atherosclerosis [23], and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis [24]. |
| PubMedID- 21270271 | We conclude that during a period of 12 years after the end of the dcct intervention, progression of atherosclerosis in patients with type 1 diabetes remains lower in the original intensive than the conventional treatment group. |
| PubMedID- 23922864 | Although the precise role of inflammation in the development of diabetic microvascular diseases is still unclear, it is likely that inflammation can accelerate atherosclerosis in patients with diabetes [14]. |
| PubMedID- 26466574 | Background: whereas a few studies have reported associations of serum omentin levels with subclinical atherosclerosis in patients with diabetes, little information is available with respect to the associations of serum omentin levels and diabetic microvascular complications. |
| PubMedID- 25851542 | [33] suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 20538123 | Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. |